2,249
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Intestinal vitamin D receptor protects against extraintestinal breast cancer tumorigenesis

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Article: 2202593 | Received 12 May 2022, Accepted 03 Apr 2023, Published online: 19 Apr 2023

References

  • Shang M, Sun J. Vitamin D/VDR, Probiotics, and Gastrointestinal diseases. Curr Med Chem. 2017;24(9):876–23. doi:10.2174/0929867323666161202150008.
  • Sun J. Dietary vitamin D, vitamin D receptor, and microbiome. Current opinion in clinical nutrition and metabolic care. Curr Opin Clin Nutr Metab Care. 2018;21(6):471–474. doi:10.1097/MCO.0000000000000516.
  • Abreu MT, Kantorovich V, Vasiliauskas EA, Gruntmanis U, Matuk R, Daigle K, Chen S, Zehnder D, Lin YC, Yang H, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxy vitamin D and low bone mineral density. Gut. 2004;53(8):1129–1136. doi:10.1136/gut.2003.036657.
  • Lim WC, Hanauer SB, Li YC. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2(7):308–315. doi:10.1038/ncpgasthep0215.
  • Sentongo TA, Semaeo EJ, Stettler N, Piccoli DA, Stallings VA, Zemel BS. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr. 2002;76(5):1077–1081. doi:10.1093/ajcn/76.5.1077.
  • Li Y, Cook KL, Yu W, Jin L, Bouker KB, Clarke R, Hilakivi-Clarke L. Inhibition of Antiestrogen-promoted pro-Survival Autophagy and Tamoxifen resistance in breast cancer through vitamin D receptor. Nutrients. 2021;13(5):1715. doi:10.3390/nu13051715.
  • Osanai M, Lee G-H. CYP24A1-induced vitamin D insufficiency promotes breast cancer growth. Oncol Rep. 2016;36(5):2755–2762. doi:10.3892/or.2016.5072.
  • Shan NL, Minden A, Furmanski P, Bak MJ, Cai L, Wernyj R, Sargsyan D, Cheng D, Wu R, Kuo HCD, et al. Analysis of the Transcriptome: regulation of cancer stemness in breast Ductal Carcinoma in situ by vitamin D compounds. Cancer Prev Res. 2020;13(8):673–686. doi:10.1158/1940-6207.CAPR-19-0566.
  • Wahler J, So JY, Cheng LC, Maehr H, Uskokovic M, Suh N. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer. J Steroid Biochem. 2015;148:148–155. doi:10.1016/j.jsbmb.2014.10.016.
  • Thorne J, Campbell MJ. The molecular cell biology of VDR. In: Trump D, Johnson C, editors, Vitamin D and Cancer. New York, NY: Springer Science & Business Media; 2011. https://doi.org/10.1007/978-1-4419-7188-3_2
  • Wu S, Zhang Y-G, Lu R, Xia Y, Zhou D, Petrof EO, Claud EC, Chen D, Chang EB, Carmeliet G, et al. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut. 2015;64(7):1082–1094. doi:10.1136/gutjnl-2014-307436.
  • Wang J, Thingholm LB, Skieceviciene J, Rausch P, Kummen M, Hov JR, Degenhardt F, Heinsen F-A, Rühlemann MC, Szymczak S, et al. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nat Genet. 2016;48(11):1396–1406. doi:10.1038/ng.3695.
  • Zhang J, Zhang Y, Xia Y, Sun J. Imbalance of the intestinal virome and altered viral-bacterial interactions caused by a conditional deletion of the vitamin D receptor. Gut Microbes. 2021;13(1):1957408. doi:10.1080/19490976.2021.1957408.
  • Zhang Y-G, Lu R, Wu S, Chatterjee I, Zhou D, Xia Y, Sun J. Vitamin D receptor protects against Dysbiosis and Tumorigenesis via the JAK/STAT pathway in intestine. Cell Mol Gastroenterol Hepatol. 2020;10(4):729–746. doi:10.1016/j.jcmgh.2020.05.010.
  • Zhang Y, Garrett S, Carroll RE, Xia Y, Sun J. Vitamin D receptor upregulates tight junction protein claudin-5 against colitis-associated tumorigenesis. Mucosal Immunol. 2022;15(4):683–697. doi:10.1038/s41385-022-00502-1.
  • Lu R, Zhang Y-G, Xia Y, Zhang J, Kaser A, Blumberg R, Sun J. Paneth cell alertness to Pathogens maintained by vitamin D receptors. Gastroenterology. 2021;160(4):1269–1283. doi:10.1053/j.gastro.2020.11.015.
  • Wu S, Liao AP, Xia Y, Li YC, Li J-D, Sartor RB, Sun J. Vitamin D receptor negatively regulates bacterial-stimulated NF-κB activity in Intestine. Am J Pathol. 2010;177(2):686–697. doi:10.2353/ajpath.2010.090998.
  • Fukata M, Abreu MT. Pathogen recognition receptors, cancer and inflammation in the gut. Curr Opin Pharmacol. 2009;9(6):680–687. doi:10.1016/j.coph.2009.09.006.
  • Bourzac KM, Guillemin K. Helicobacter pylori-host cell interactions mediated by type IV secretion. Cell Microbiol. 2005;7(7):911–919. doi:10.1111/j.1462-5822.2005.00541.x.
  • Bourzac KM, Satkamp LA, Guillemin K. The Helicobacter pylori cag pathogenicity island protein CagN is a bacterial membrane-associated protein that is processed at its C terminus. Infect Immun. 2006;74(5):2537–2543. doi:10.1128/IAI.74.5.2537-2543.2006.
  • Gobert AP, McGee DJ, Akhtar M, Mendz GL, Newton JC, Cheng Y, Mobley HLT, Wilson KT. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci U S A. 2001;98(24):13844–13849. doi:10.1073/pnas.241443798.
  • Yan F, Cao H, Chaturvedi R, Krishna U, Hobbs SS, Dempsey PJ, Peek RM, Cover TL, Washington MK, Wilson KT, et al. Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. Gastroenterology. 2009;136(4):1297–3. doi:10.1053/j.gastro.2008.12.059.
  • Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology. 2010;138(6):2101–14 e5. doi:10.1053/j.gastro.2010.01.058.
  • Iqbal MUN, Khan TA. Association between vitamin D receptor (Cdx2, Fok1, Bsm1, Apa1, Bgl1, Taq1, and Poly (A)) gene polymorphism and breast cancer: a systematic review and meta-analysis. Tumor Biol. 2017;39(10):1010428317731280. doi:10.1177/1010428317731280.
  • Atoum M, Alzoughool F. Vitamin D and breast cancer: latest evidence and future steps. Breast Cancer Basic Clin Res. 2017;11:1178223417749816. doi:10.1177/1178223417749816.
  • Al-Azhri J, Zhang Y, Bshara W, Zirpoli G, McCann SE, Khoury T, Morrison CD, Edge SB, Ambrosone CB, Yao S. Tumor expression of vitamin D receptor and breast cancer histopathological characteristics and prognosis. Clin Cancer Res. 2017;23(1):97–103. doi:10.1158/1078-0432.CCR-16-0075.
  • Zhang YG, Wu S, Sun J. Vitamin D, vitamin D receptor and tissue barriers. Tissue Barriers. 2013;1(1):1. doi:10.4161/tisb.23118.
  • Song M, Chan AT, Sun J. Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology. 2020;158(2):322–340. doi:10.1053/j.gastro.2019.06.048.
  • Welsh J. Vitamin D and breast cancer: past and present. J Steroid Biochem Mol Biol. 2018;177:15–20. doi:10.1016/j.jsbmb.2017.07.025.
  • González-Beiras C, Marks M, Chen CY, Roberts S, Mitjà O. Epidemiology of Haemophilus ducreyi infections. Emerg Infect Dis. 2016;22(1):1–8. doi:10.3201/eid2201.150425.
  • Luo S, Yin J, Peng Y, Xie J, Wu H, He D, Li X, Cheng G. Glutathione is Involved in Detoxification of Peroxide and root nodule symbiosis of Mesorhizobium huakuii. Curr Microbiol. 2020;77(1):1–10. doi:10.1007/s00284-019-01784-8.
  • Komaniecka I, Zdzisinska B, Kandefer-Szerszen M, Choma A. Low endotoxic activity of lipopolysaccharides isolated from Bradyrhizobium, Mesorhizobium, and Azospirillum strains. Microbiol Immunol. 2010;54(12):717–725. doi:10.1111/j.1348-0421.2010.00269.x.
  • Hudspeth DS, Vary PS. spoVG sequence of Bacillus megaterium and Bacillus subtilis. Biochim Biophys Acta. 1992;1130(2):229–231. doi:10.1016/0167-4781(92)90536-9.
  • Holeček M. Histidine in health and disease: metabolism, physiological importance, and use as a supplement. Nutrients. 2020;12(3):848. doi:10.3390/nu12030848.
  • Kulis-Horn RK, Persicke M, Kalinowski J. Histidine biosynthesis, its regulation and biotechnological application in Corynebacterium glutamicum. Microb Biotechnol. 2014;7(1):5–25. doi:10.1111/1751-7915.12055.
  • Zhang J, Xia Y, Sun J. Breast and gut microbiome in health and cancer. Genes Dis. 2021;8(5):581–589. doi:10.1016/j.gendis.2020.08.002.
  • Yang J, Tan Q, Fu Q, Zhou Y, Hu Y, Tang S, Zhou Y, Zhang J, Qiu J, Lv Q. Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications. Breast Cancer. 2017;24(2):220–228. doi:10.1007/s12282-016-0734-z.
  • Soto-Pantoja DR, Gaber M, Arnone AA, Bronson SM, Cruz-Diaz N, Wilson AS, Clear KYJ, Ramirez MU, Kucera GL, Levine EA, et al. Diet alters entero-mammary signaling to regulate the breast microbiome and Tumorigenesis. Cancer Res. 2021;81(14):3890–3904. doi:10.1158/0008-5472.CAN-20-2983.
  • Buchta Rosean C, Bostic RR, Ferey JCM, Feng TY, Azar FN, Tung KS, Dozmorov MG, Smirnova E, Bos PD, Rutkowski MR. Preexisting Commensal Dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in Hormone Receptor–Positive Breast Cancer. Cancer Res. 2019;79(14):3662–3675. doi:10.1158/0008-5472.CAN-18-3464.
  • Zhu J, Liao M, Yao ZT, Liang WY, Li QB, Liu JL, Yang H, Ji Y, Wei W, Tan A, et al. Breast cancer in postmenopausal women is associated with an altered gut metagenome. Microbiome. 2018;6(1):6. doi:10.1186/s40168-018-0515-3.
  • Huggins C, Grand LC, Brillantes FP. Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression. Nature. 1961;189(4760):204–207. doi:10.1038/189204a0.
  • Ethier SP, Ullrich RL. Induction of mammary tumors in virgin female BALB/c mice by single low doses of 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst. 1982;69:1199–1203.
  • Currier N, Solomon SE, Demicco EG, Chang DL, Farago M, Ying H, Dominguez I, Sonenshein GE, Cardiff RD, Xiao ZXJ, et al. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol Pathol. 2005;33(6):726–737. doi:10.1080/01926230500352226.
  • Abba MC, Zhong Y, Lee J, Kil H, Lu Y, Takata Y, Simper MS, Gaddis S, Shen J, Aldaz CM. DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations. Oncotarget. 2016;7(39):64289–64299. doi:10.18632/oncotarget.11733.
  • Lee G, Goretsky T, Managlia E, Dirisina R, Singh AP, Brown JB, May R, Yang G, Ragheb JW, Evers BM, et al. Phosphoinositide 3-Kinase signaling mediates β-catenin activation in intestinal epithelial stem and Progenitor cells in Colitis. Gastroenterology. 2010;139(3):869–9. doi:10.1053/j.gastro.2010.05.037.
  • Wang S, Han Y, Zhang J, Yang S, Fan Z, Song F, He L, Yue W, Li Y, Pei X. Me6tren targets β-catenin signaling to stimulate intestinal stem cell regeneration after radiation. Theranostics. 2020;10(22):10171–10185. doi:10.7150/thno.46415.
  • Perry JM, Tao F, Roy A, Lin T, He XC, Chen S, Lu X, Nemechek J, Ruan L, Yu X, et al. Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells. Nat Cell Biol. 2020;22(6):689–700. doi:10.1038/s41556-020-0507-y.
  • Zeng MY, Inohara N, Nunez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 2017;10(1):18–26. doi:10.1038/mi.2016.75.
  • Louis P, Duncan SH, McCrae SI, Millar J, Jackson MS, Flint HJ. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J Bacteriol. 2004;186(7):2099–2106. doi:10.1128/JB.186.7.2099-2106.2004.
  • Thompson KJ, Ingle JN, Tang X, Chia N, Jeraldo PR, Walther-Antonio MR, Kandimalla KK, Johnson S, Yao JZ, Harrington SC, et al. A comprehensive analysis of breast cancer microbiota and host gene expression. Plos One. 2017;12(11):e0188873. doi:10.1371/journal.pone.0188873.
  • O’Connor H, MacSharry J, Bueso YF, Lindsay S, Kavanagh EL, Tangney M, Clyne M, Saldova R, McCann A. Resident bacteria in breast cancer tissue: pathogenic agents or harmless commensals? Discov Med. 2018;26:93–102.
  • Wu SP, Yoon S, Zhang YG, Lu R, Xia YL, Wan JD, Petrof EO, Claud EC, Chen D, Sun J. Vitamin D receptor pathway is required for probiotic protection in colitis. Am J Physiol-Gastr L. 2015;309(5):G341–9. doi:10.1152/ajpgi.00105.2015.
  • Kusumo PD, Maulahela H, Utari AP, Surono IS, Soebandrio A, Abdullah M. Probiotic Lactobacillus plantarum is 10506 supplementation increase SCFA of women with functional constipation. Iran J Microbiol. 2019;11:389–396.
  • Moens F, Van den Abbeele P, Basit AW, Dodoo C, Chatterjee R, Smith B, Gaisford S. A four-strain probiotic exerts positive immunomodulatory effects by enhancing colonic butyrate production in vitro. Int J Pharm. 2019;555:1–10. doi:10.1016/j.ijpharm.2018.11.020.
  • Zhang J, Lu R, Zhang Y, Matuszek Z, Zhang W, Xia Y, Pan T, Sun J. tRNA queuosine modification enzyme modulates the growth and microbiome recruitment to breast tumors. Cancers (Basel). 2020;12(3):628 doi:10.3390/cancers12030628
  • De Mattia E, Cecchin E, Montico M, Labriet A, Guillemette C, Dreussi E, Roncato R, Bignucolo A, Buonadonna A, D’Andrea M, et al. Association of STAT-3 rs1053004 and VDR rs11574077 with FOLFIRI-Related GastrointestinaL toxicity in metastatic colorectal cancer patients. Front Pharmacol. 2018;9:367. doi:10.3389/fphar.2018.00367.
  • Zinser GM, Welsh J. Effect of Vitamin D3 receptor ablation on murine mammary gland development and tumorigenesis. J Steroid Biochem Mol Biol. 2004;89-90:433–436. doi:10.1016/j.jsbmb.2004.03.012.
  • ABE J, NAKANO T, NISHII Y, MATSUMOTO T, OGATA E, IKEDA K. A novel vitamin D3 analog, 22-oxa-1, 25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology. 1991;129(2):832–837. doi:10.1210/endo-129-2-832.
  • Fu A, Yao B, Dong T, Chen Y, Yao J, Liu Y, Li H, Bai H, Liu X, Zhang Y, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185(8):1356–72 e26. doi:10.1016/j.cell.2022.02.027.
  • Parida S, Wu S, Siddharth S, Wang G, Muniraj N, Nagalingam A, Hum C, Mistriotis P, Hao H, Talbot CC, et al. A Procarcinogenic colon microbe promotes breast Tumorigenesis and metastatic progression and concomitantly activates notch and β-Catenin Axes. Cancer Discov. 2021;11(5):1138–1157. doi:10.1158/2159-8290.CD-20-0537.
  • Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G, Goodrich-Blair H. The microbiota of breast tissue and its association with breast cancer. Appl Environ Microbiol. 2016;82(16):5039–5048. doi:10.1128/AEM.01235-16.
  • Riviere A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and Butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol. 2016;7:979. doi:10.3389/fmicb.2016.00979.
  • Sun J, Zhang Y-G. Vitamin D receptor influences intestinal barriers in health and disease. Cells. 2022;11(7):11. doi:10.3390/cells11071129.
  • Soldatenkov VA, Prasad S, Voloshin Y, Dritschilo A. Sodium butyrate induces apoptosis and accumulation of ubiquitinated proteins in human breast carcinoma cells. Cell Death Differ. 1998;5(4):307–312. doi:10.1038/sj.cdd.4400345.
  • Protiva P, Cross HS, Hopkins ME, Kallay E, Bises G, Dreyhaupt E, Augenlicht L, Lipkin M, Lesser M, Livote E, et al. Chemoprevention of colorectal neoplasia by estrogen: potential role of vitamin D activity. Cancer Prev Res (Phila Pa). 2009;2(1):43–51. doi:10.1158/1940-6207.CAPR-08-0103.
  • Murillo G, Mehta RG. Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1α-hydroxyvitamin D5. J Steroid Biochem Mol Biol. 2005;97(1–2):129–136. doi:10.1016/j.jsbmb.2005.06.008.
  • Kaler P, Augenlicht L, Klampfer L. Macrophage-derived IL-1β stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene. 2009;28(44):3892–3902. doi:10.1038/onc.2009.247.
  • Fichera A, Little N, Dougherty U, Mustafi R, Cerda S, Li YC, Delgado J, Arora A, Campbell LK, Joseph L, et al. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model. J Surg Res. 2007;142(2):239–245. doi:10.1016/j.jss.2007.02.038.
  • Nagpal S, Lu J, Boehm MF. Vitamin D analogs: mechanism of action and therapeutic applications. curr Med Chem. 2001;8(13):1661–1679. doi:10.2174/0929867013371950.
  • Palmer HG, Sanchez-Carbayo M, Ordonez-Moran P, Larriba MJ, Cordon-Cardo C, Munoz A. Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res. 2003;63:7799–7806.
  • Chan AT, Giovannucci EL. Primary prevention of colorectal cancer. Gastroenterology. 2010;138(6):2029–43 e10. doi:10.1053/j.gastro.2010.01.057.
  • Gombart AF, Luong QT, Koeffler HP. Vitamin D compounds: activity against microbes and cancer. Anticancer Res. 2006;26:2531–2542.
  • Welsh J, Wietzke JA, Zinser GM, Byrne B, Smith K, Narvaez CJ. Vitamin D-3 receptor as a target for breast cancer prevention. J Nutr. 2003;133(7):2425S–2433S. doi:10.1093/jn/133.7.2425S.
  • Zhang Y-G, Lu R, Xia Y, Zhou D, Petrof E, Claud EC, Sun J. Lack of vitamin D receptor leads to hyperfunction of Claudin-2 in intestinal inflammatory responses. Inflamm Bowel Dis. 2018;25:97–110. doi:10.1093/ibd/izy292.
  • Zhang Y-G, Lu R, Wu S, Chatterjee I, Zhou D, Xia Y, Sun, J. Vitamin D receptor protects against dysbiosis and tumorigenesis via the JAK/STAT pathway in intestine. bioRxiv. 2020;2(18):946335.
  • Faustino-Rocha A, Oliveira PA, Pinho-Oliveira J, Teixeira-Guedes C, Soares-Maia R, da Costa RG, Colaço B, Pires MJ, Colaço J, Ferreira R, et al. Estimation of rat mammary tumor volume using caliper and ultrasonography measurements. Lab Anim (NY). 2013;42(6):217–224. doi:10.1038/laban.254.
  • Zhang YG, Lu R, Xia Y, Zhou D, Petrof E, Claud EC, Sun J. Lack oF vitamin d receptor leads to hyperfunction of claudin-2 in intestinal inflammatory responses. Inflamm Bowel Dis. 2019;25:97–110. doi:10.1093/ibd/izy292.
  • Lu R, Wu S, Liu X, Xia Y, Zhang Y-G, Sun J, Bereswill S. Chronic effects of a Salmonella type III secretion effector protein AvrA in vivo. Plos One. 2010;5(5):e10505. doi:10.1371/journal.pone.0010505.
  • Chatterjee I, Lu R, Zhang Y, Zhang J, Dai Y, Xia Y, Sun J. Vitamin D receptor promotes healthy microbial metabolites and microbiome. Sci Rep. 2020;10(1):7340. doi:10.1038/s41598-020-64226-7.
  • Xia Y, Sun J, Chen D-G. Bioinformatic analysis of microbiome data. Singapore: Statistical Analysis of Microbiome Data with R: Springer; 2018.
  • Kim D, Song L, Breitwieser FP, Salzberg SL. Centrifuge: rapid and sensitive classification of metagenomic sequences. Genome Res. 2016;26(12):1721–1729. doi:10.1101/gr.210641.116.